Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 10 | 2025 | 491 | 1.200 |
Why?
|
| Surgeons | 5 | 2025 | 181 | 0.780 |
Why?
|
| Vesico-Ureteral Reflux | 3 | 2011 | 15 | 0.710 |
Why?
|
| Braces | 2 | 2014 | 10 | 0.690 |
Why?
|
| Child | 30 | 2025 | 4522 | 0.660 |
Why?
|
| Hospitals | 2 | 2023 | 392 | 0.640 |
Why?
|
| Intestinal Obstruction | 3 | 2012 | 53 | 0.620 |
Why?
|
| Specialties, Surgical | 3 | 2025 | 48 | 0.590 |
Why?
|
| Urinary Tract Infections | 2 | 2011 | 90 | 0.580 |
Why?
|
| Child, Preschool | 18 | 2025 | 1988 | 0.550 |
Why?
|
| Appendicitis | 3 | 2018 | 81 | 0.550 |
Why?
|
| Pectus Carinatum | 1 | 2014 | 4 | 0.440 |
Why?
|
| Infant | 15 | 2025 | 1649 | 0.420 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 20 | 0.390 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2012 | 34 | 0.380 |
Why?
|
| Treatment Outcome | 15 | 2025 | 5656 | 0.370 |
Why?
|
| Adolescent | 21 | 2025 | 6238 | 0.370 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 288 | 0.370 |
Why?
|
| Bites and Stings | 1 | 2011 | 11 | 0.370 |
Why?
|
| Facial Injuries | 1 | 2011 | 14 | 0.360 |
Why?
|
| Humans | 55 | 2025 | 63293 | 0.360 |
Why?
|
| Cicatrix | 2 | 2011 | 61 | 0.360 |
Why?
|
| Wound Infection | 1 | 2011 | 28 | 0.360 |
Why?
|
| Colectomy | 1 | 2012 | 108 | 0.350 |
Why?
|
| Dextrans | 2 | 2009 | 46 | 0.350 |
Why?
|
| Pediatrics | 2 | 2025 | 254 | 0.350 |
Why?
|
| Retrospective Studies | 17 | 2025 | 6630 | 0.340 |
Why?
|
| Prostheses and Implants | 2 | 2009 | 71 | 0.340 |
Why?
|
| Hyaluronic Acid | 2 | 2009 | 67 | 0.330 |
Why?
|
| Dogs | 1 | 2011 | 325 | 0.330 |
Why?
|
| Wounds, Nonpenetrating | 3 | 2015 | 108 | 0.320 |
Why?
|
| Male | 32 | 2025 | 29821 | 0.310 |
Why?
|
| Hernia, Inguinal | 2 | 2022 | 42 | 0.310 |
Why?
|
| Postoperative Complications | 5 | 2025 | 1302 | 0.310 |
Why?
|
| Herniorrhaphy | 3 | 2025 | 70 | 0.300 |
Why?
|
| Infant, Newborn | 13 | 2025 | 1355 | 0.290 |
Why?
|
| Fundoplication | 2 | 2025 | 25 | 0.280 |
Why?
|
| Female | 30 | 2025 | 32791 | 0.280 |
Why?
|
| Thoracoscopy | 3 | 2004 | 25 | 0.280 |
Why?
|
| Laparoscopes | 1 | 2007 | 25 | 0.280 |
Why?
|
| Touch | 1 | 2007 | 27 | 0.270 |
Why?
|
| Jejunal Diseases | 1 | 2007 | 7 | 0.270 |
Why?
|
| Choristoma | 1 | 2007 | 22 | 0.270 |
Why?
|
| Intussusception | 1 | 2007 | 14 | 0.270 |
Why?
|
| Stomach | 1 | 2007 | 86 | 0.260 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 126 | 0.260 |
Why?
|
| Spleen | 2 | 2012 | 483 | 0.250 |
Why?
|
| Sternum | 1 | 2006 | 29 | 0.250 |
Why?
|
| Thoracic Wall | 1 | 2006 | 20 | 0.250 |
Why?
|
| Sutures | 2 | 2016 | 41 | 0.250 |
Why?
|
| Biocompatible Materials | 1 | 2007 | 150 | 0.240 |
Why?
|
| Anus, Imperforate | 1 | 2005 | 4 | 0.240 |
Why?
|
| Catheterization, Central Venous | 2 | 1997 | 87 | 0.240 |
Why?
|
| Urethral Diseases | 1 | 2005 | 13 | 0.240 |
Why?
|
| Urinary Fistula | 1 | 2005 | 17 | 0.240 |
Why?
|
| Gastroesophageal Reflux | 2 | 2025 | 92 | 0.240 |
Why?
|
| Histamine H2 Antagonists | 1 | 2025 | 15 | 0.240 |
Why?
|
| Colonic Diseases | 1 | 2005 | 34 | 0.240 |
Why?
|
| Hernia, Umbilical | 1 | 2025 | 7 | 0.240 |
Why?
|
| Rectal Fistula | 1 | 2005 | 21 | 0.240 |
Why?
|
| Occupational Stress | 1 | 2025 | 20 | 0.230 |
Why?
|
| Proton Pump Inhibitors | 1 | 2025 | 42 | 0.230 |
Why?
|
| Occupational Injuries | 1 | 2025 | 35 | 0.230 |
Why?
|
| Urethra | 1 | 2005 | 75 | 0.230 |
Why?
|
| Ergonomics | 1 | 2025 | 79 | 0.230 |
Why?
|
| Continuity of Patient Care | 1 | 2025 | 174 | 0.210 |
Why?
|
| Follow-Up Studies | 6 | 2025 | 2458 | 0.210 |
Why?
|
| Meckel Diverticulum | 1 | 2003 | 3 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 1618 | 0.200 |
Why?
|
| Anesthesia, Spinal | 1 | 2022 | 30 | 0.190 |
Why?
|
| Musa | 1 | 2021 | 7 | 0.190 |
Why?
|
| Hypocalcemia | 1 | 2022 | 19 | 0.190 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2021 | 8 | 0.190 |
Why?
|
| Stomach Volvulus | 1 | 2001 | 3 | 0.180 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 8 | 0.180 |
Why?
|
| Referral and Consultation | 1 | 2025 | 422 | 0.180 |
Why?
|
| Splenic Diseases | 1 | 2001 | 15 | 0.180 |
Why?
|
| Intestinal Atresia | 1 | 2001 | 2 | 0.180 |
Why?
|
| Duodenal Obstruction | 1 | 2001 | 4 | 0.180 |
Why?
|
| Common Bile Duct | 1 | 2001 | 19 | 0.180 |
Why?
|
| Esophageal Atresia | 2 | 2004 | 9 | 0.180 |
Why?
|
| Length of Stay | 4 | 2015 | 811 | 0.180 |
Why?
|
| Boston | 1 | 2022 | 252 | 0.180 |
Why?
|
| Physician Assistants | 1 | 2020 | 36 | 0.170 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 117 | 0.160 |
Why?
|
| Pediatricians | 1 | 2020 | 52 | 0.160 |
Why?
|
| Appendix | 1 | 2018 | 17 | 0.150 |
Why?
|
| Lung | 1 | 2004 | 953 | 0.150 |
Why?
|
| Cell Respiration | 1 | 2018 | 21 | 0.150 |
Why?
|
| Hospital Mortality | 2 | 2013 | 874 | 0.140 |
Why?
|
| Neuroblastoma | 1 | 2018 | 52 | 0.140 |
Why?
|
| Fibroblasts | 2 | 1997 | 387 | 0.140 |
Why?
|
| Phytotherapy | 1 | 2018 | 53 | 0.140 |
Why?
|
| Hypertension, Renal | 1 | 1997 | 5 | 0.140 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1997 | 6 | 0.140 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1997 | 16 | 0.130 |
Why?
|
| Staphylococcal Infections | 2 | 2011 | 129 | 0.130 |
Why?
|
| Parenteral Nutrition | 1 | 1997 | 21 | 0.130 |
Why?
|
| Abdomen, Acute | 1 | 1997 | 23 | 0.130 |
Why?
|
| Pharynx | 1 | 1997 | 25 | 0.130 |
Why?
|
| Hematoma | 1 | 1997 | 80 | 0.130 |
Why?
|
| Plant Extracts | 1 | 2018 | 172 | 0.130 |
Why?
|
| Cerebral Infarction | 1 | 1997 | 83 | 0.130 |
Why?
|
| Blood Proteins | 1 | 1996 | 76 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2018 | 483 | 0.130 |
Why?
|
| Esophagostomy | 1 | 1996 | 1 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 2571 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 536 | 0.120 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1996 | 21 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 417 | 0.120 |
Why?
|
| Catheters, Indwelling | 1 | 1996 | 69 | 0.120 |
Why?
|
| Enteral Nutrition | 1 | 1996 | 54 | 0.120 |
Why?
|
| Extracellular Matrix | 1 | 1996 | 139 | 0.120 |
Why?
|
| Postoperative Care | 1 | 1996 | 123 | 0.120 |
Why?
|
| Pancreas | 1 | 2015 | 150 | 0.120 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 972 | 0.110 |
Why?
|
| Kidney | 1 | 1997 | 447 | 0.110 |
Why?
|
| Age Factors | 3 | 2013 | 1559 | 0.110 |
Why?
|
| Child Advocacy | 1 | 2013 | 7 | 0.100 |
Why?
|
| Drainage | 2 | 2011 | 154 | 0.100 |
Why?
|
| Odds Ratio | 2 | 2013 | 768 | 0.100 |
Why?
|
| Incidence | 3 | 2013 | 1375 | 0.100 |
Why?
|
| Soft Tissue Infections | 2 | 2011 | 49 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 663 | 0.100 |
Why?
|
| Wounds, Gunshot | 1 | 2013 | 56 | 0.100 |
Why?
|
| Community-Acquired Infections | 2 | 2011 | 94 | 0.100 |
Why?
|
| Ovarian Cysts | 1 | 2012 | 4 | 0.100 |
Why?
|
| Hospital Charges | 1 | 2012 | 23 | 0.100 |
Why?
|
| United States | 6 | 2025 | 7825 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 49 | 0.090 |
Why?
|
| Wounds, Penetrating | 1 | 2012 | 26 | 0.090 |
Why?
|
| Firearms | 1 | 2013 | 69 | 0.090 |
Why?
|
| Neutropenia | 1 | 2012 | 67 | 0.090 |
Why?
|
| Pain, Postoperative | 2 | 2025 | 163 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2012 | 240 | 0.090 |
Why?
|
| Rectum | 2 | 2005 | 89 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 1543 | 0.090 |
Why?
|
| Equipment Design | 2 | 2007 | 349 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2014 | 360 | 0.090 |
Why?
|
| Appendectomy | 2 | 2018 | 54 | 0.090 |
Why?
|
| Soft Tissue Injuries | 1 | 2011 | 21 | 0.090 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 55 | 0.090 |
Why?
|
| Unnecessary Procedures | 1 | 2011 | 49 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2012 | 498 | 0.090 |
Why?
|
| Ureteroscopy | 1 | 2011 | 17 | 0.090 |
Why?
|
| Operating Rooms | 1 | 2011 | 55 | 0.090 |
Why?
|
| Esophagus | 2 | 2004 | 50 | 0.090 |
Why?
|
| Emergencies | 1 | 2011 | 120 | 0.090 |
Why?
|
| Suture Techniques | 1 | 2011 | 100 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 65 | 0.080 |
Why?
|
| Acute Disease | 1 | 2012 | 672 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 2674 | 0.080 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2010 | 12 | 0.080 |
Why?
|
| Surgical Stapling | 1 | 2010 | 12 | 0.080 |
Why?
|
| Gastroscopy | 1 | 2010 | 21 | 0.080 |
Why?
|
| Gastrostomy | 1 | 2010 | 29 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 192 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1649 | 0.080 |
Why?
|
| Splenectomy | 2 | 2012 | 42 | 0.070 |
Why?
|
| Bacteriuria | 1 | 2007 | 16 | 0.070 |
Why?
|
| Escherichia coli Infections | 1 | 2007 | 87 | 0.060 |
Why?
|
| Cardiac Output | 1 | 2005 | 28 | 0.060 |
Why?
|
| Funnel Chest | 1 | 2005 | 7 | 0.060 |
Why?
|
| Wound Healing | 2 | 2016 | 189 | 0.060 |
Why?
|
| Gynecomastia | 1 | 2005 | 11 | 0.060 |
Why?
|
| Prostatic Diseases | 1 | 2005 | 9 | 0.060 |
Why?
|
| Breast Neoplasms, Male | 1 | 2005 | 14 | 0.060 |
Why?
|
| Adult | 7 | 2025 | 16781 | 0.060 |
Why?
|
| Physical Endurance | 1 | 2005 | 48 | 0.060 |
Why?
|
| Urinary Catheterization | 1 | 2005 | 19 | 0.060 |
Why?
|
| Colostomy | 1 | 2005 | 24 | 0.060 |
Why?
|
| Methicillin Resistance | 1 | 2005 | 23 | 0.060 |
Why?
|
| Exercise Tolerance | 1 | 2005 | 79 | 0.060 |
Why?
|
| Geographic Information Systems | 1 | 2005 | 23 | 0.060 |
Why?
|
| Recurrence | 1 | 2007 | 642 | 0.060 |
Why?
|
| Umbilicus | 1 | 2025 | 16 | 0.060 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 26 | 0.060 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2005 | 52 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 784 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2007 | 3285 | 0.060 |
Why?
|
| Operative Time | 1 | 2025 | 92 | 0.060 |
Why?
|
| Esophagoplasty | 1 | 2004 | 4 | 0.060 |
Why?
|
| Insufflation | 1 | 2004 | 9 | 0.050 |
Why?
|
| Reoperation | 1 | 2025 | 289 | 0.050 |
Why?
|
| Animals | 4 | 2016 | 20634 | 0.050 |
Why?
|
| Pressure | 1 | 2004 | 79 | 0.050 |
Why?
|
| Hand Injuries | 1 | 2003 | 11 | 0.050 |
Why?
|
| Models, Animal | 1 | 2004 | 236 | 0.050 |
Why?
|
| Burns | 1 | 2003 | 41 | 0.050 |
Why?
|
| Swine | 1 | 2004 | 374 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2003 | 79 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 25 | 0.050 |
Why?
|
| Ligation | 1 | 2022 | 39 | 0.050 |
Why?
|
| Biopsy | 1 | 2004 | 444 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 935 | 0.050 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2002 | 11 | 0.050 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2022 | 4 | 0.050 |
Why?
|
| Hepatoblastoma | 1 | 2002 | 9 | 0.050 |
Why?
|
| Pylorus | 1 | 2021 | 10 | 0.050 |
Why?
|
| Thyroidectomy | 1 | 2022 | 31 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2002 | 99 | 0.050 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2001 | 24 | 0.050 |
Why?
|
| Mouth Diseases | 1 | 2001 | 13 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2025 | 511 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 2022 | 81 | 0.050 |
Why?
|
| Cisplatin | 1 | 2002 | 139 | 0.050 |
Why?
|
| Airway Obstruction | 1 | 2001 | 38 | 0.050 |
Why?
|
| Laparotomy | 1 | 2001 | 52 | 0.040 |
Why?
|
| Endoscopy, Digestive System | 1 | 2001 | 33 | 0.040 |
Why?
|
| Cysts | 1 | 2001 | 41 | 0.040 |
Why?
|
| Urogenital System | 1 | 2001 | 3 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2015 | 869 | 0.040 |
Why?
|
| Logistic Models | 2 | 2015 | 1275 | 0.040 |
Why?
|
| Cesarean Section | 2 | 2001 | 99 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2013 | 2077 | 0.040 |
Why?
|
| Fetus | 2 | 2001 | 98 | 0.040 |
Why?
|
| Radiography | 1 | 2001 | 548 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 297 | 0.040 |
Why?
|
| Birth Injuries | 1 | 1998 | 2 | 0.040 |
Why?
|
| Rectovaginal Fistula | 1 | 1998 | 3 | 0.040 |
Why?
|
| Vaginal Diseases | 1 | 1998 | 7 | 0.040 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 10 | 0.040 |
Why?
|
| Cytotoxins | 1 | 2018 | 12 | 0.040 |
Why?
|
| Pheochromocytoma | 1 | 1998 | 26 | 0.040 |
Why?
|
| Rhodiola | 1 | 2018 | 15 | 0.040 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1998 | 43 | 0.040 |
Why?
|
| Rectal Diseases | 1 | 1998 | 28 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 447 | 0.040 |
Why?
|
| Vagina | 1 | 1998 | 83 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 571 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2020 | 406 | 0.030 |
Why?
|
| Femoral Vein | 1 | 1997 | 19 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2016 | 84 | 0.030 |
Why?
|
| Collagen | 1 | 1997 | 123 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 199 | 0.030 |
Why?
|
| Esophageal Achalasia | 1 | 1997 | 37 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 569 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2010 | 129 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1996 | 2 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 1996 | 12 | 0.030 |
Why?
|
| Tracheoesophageal Fistula | 1 | 1996 | 4 | 0.030 |
Why?
|
| Jugular Veins | 1 | 1996 | 29 | 0.030 |
Why?
|
| Equipment Safety | 1 | 1996 | 22 | 0.030 |
Why?
|
| Exercise | 1 | 2003 | 939 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1997 | 185 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 712 | 0.030 |
Why?
|
| Gestational Age | 1 | 1996 | 189 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2015 | 109 | 0.030 |
Why?
|
| Ischemia | 1 | 1997 | 204 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2012 | 2570 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 1997 | 247 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2180 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 1465 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 985 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 640 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 1006 | 0.030 |
Why?
|
| Urban Population | 1 | 2013 | 193 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 4682 | 0.020 |
Why?
|
| Cell Line | 1 | 1996 | 2037 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 581 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1998 | 2167 | 0.020 |
Why?
|
| Poverty | 1 | 2013 | 296 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 777 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 253 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 259 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 979 | 0.020 |
Why?
|
| Clavulanic Acids | 1 | 1989 | 2 | 0.020 |
Why?
|
| Ticarcillin | 1 | 1989 | 3 | 0.020 |
Why?
|
| Clindamycin | 1 | 1989 | 13 | 0.020 |
Why?
|
| Penicillins | 1 | 1989 | 30 | 0.020 |
Why?
|
| Gentamicins | 1 | 1989 | 25 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2011 | 220 | 0.020 |
Why?
|
| Retreatment | 1 | 2009 | 47 | 0.020 |
Why?
|
| Middle Aged | 2 | 2025 | 17553 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1989 | 149 | 0.020 |
Why?
|
| Mastectomy, Simple | 1 | 2005 | 2 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2005 | 41 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2005 | 134 | 0.010 |
Why?
|
| Sus scrofa | 1 | 2004 | 29 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 252 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 176 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 114 | 0.010 |
Why?
|
| Accidents, Home | 1 | 2003 | 10 | 0.010 |
Why?
|
| Contracture | 1 | 2003 | 9 | 0.010 |
Why?
|
| Finger Injuries | 1 | 2003 | 16 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2003 | 104 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2003 | 156 | 0.010 |
Why?
|
| Pregnancy | 2 | 2001 | 2330 | 0.010 |
Why?
|
| Aged | 2 | 1996 | 14394 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2004 | 568 | 0.010 |
Why?
|
| Fetal Monitoring | 1 | 2001 | 6 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2001 | 46 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2001 | 43 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2001 | 112 | 0.010 |
Why?
|
| Circumcision, Male | 1 | 2001 | 10 | 0.010 |
Why?
|
| Placenta | 1 | 2001 | 61 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2002 | 192 | 0.010 |
Why?
|
| Massachusetts | 1 | 2005 | 2077 | 0.010 |
Why?
|
| Breech Presentation | 1 | 1998 | 1 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 1998 | 242 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1998 | 152 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1997 | 37 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1998 | 166 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1997 | 488 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 172 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1997 | 373 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 517 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1998 | 554 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 5343 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 1200 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1997 | 2152 | 0.010 |
Why?
|
| Abdomen | 1 | 1989 | 91 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1989 | 463 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1989 | 735 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1989 | 5446 | 0.000 |
Why?
|